BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33127558)

  • 1. Hepatic Autophagy Deficiency Remodels Gut Microbiota for Adaptive Protection via FGF15-FGFR4 Signaling.
    Yan S; Khambu B; Chen X; Dong Z; Guo G; Yin XM
    Cell Mol Gastroenterol Hepatol; 2021; 11(4):973-997. PubMed ID: 33127558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling.
    Qiu Y; Yu J; Li Y; Yang F; Yu H; Xue M; Zhang F; Jiang X; Ji X; Bao Z
    Ann Med; 2021 Dec; 53(1):508-522. PubMed ID: 33783283
    [No Abstract]   [Full Text] [Related]  

  • 3. Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.
    Hernandez GV; Smith VA; Melnyk M; Burd MA; Sprayberry KA; Edwards MS; Peterson DG; Bennet DC; Fanter RK; Columbus DA; Steibel JP; Glanz H; Immoos C; Rice MS; Santiago-Rodriguez TM; Blank J; VanderKelen JJ; Kitts CL; Piccolo BD; La Frano MR; Burrin DG; Maj M; Manjarin R
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G582-G609. PubMed ID: 32003601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvia-Nelumbinis naturalis extract protects mice against MCD diet-induced steatohepatitis via activation of colonic FXR-FGF15 pathway.
    Li C; Zhou W; Li M; Shu X; Zhang L; Ji G
    Biomed Pharmacother; 2021 Jul; 139():111587. PubMed ID: 33865013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor.
    Gadaleta RM; Garcia-Irigoyen O; Cariello M; Scialpi N; Peres C; Vetrano S; Fiorino G; Danese S; Ko B; Luo J; Porru E; Roda A; Sabbà C; Moschetta A
    EBioMedicine; 2020 Apr; 54():102719. PubMed ID: 32259714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes.
    Rizzolo D; Kong B; Piekos S; Chen L; Zhong X; Lu J; Shi J; Zhu HJ; Yang Q; Li A; Li L; Wang H; Siemiątkowska A; Park C; Kagan L; Guo GL
    Drug Metab Dispos; 2022 Apr; 50(4):468-477. PubMed ID: 34965924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibuprofen induces hepatic Cyp7a1 expression in mice via the intestinal FXR-FGF15 signaling.
    Li H; Xiong H; Wang X; Xu T; Zhang C; Zhang W; Zhang Y
    Toxicol Lett; 2024 May; 398():1-12. PubMed ID: 38815664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intestine-specific deletion of FGF15 on the development of fatty liver disease with vertical sleeve gastrectomy.
    Chow MD; Otersen K; Wassef A; Kong B; Yamarthy S; Rizzolo D; Yang I; Buckley B; Lu A; Crook N; Lee M; Gao J; Naganand S; Stofan MF; Armstrong L; Schumacher J; Taylor R; Henry Z; Basaly V; Yang Z; Zhang M; Huang M; Kagan L; Brunetti L; Sadek R; Lee YH; Guo GL
    Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38780301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotic-derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation.
    Jiang M; Li F; Liu Y; Gu Z; Zhang L; Lee J; He L; Vatsalya V; Zhang HG; Deng Z; Zhang X; Chen SY; Guo GL; Barve S; McClain CJ; Feng W
    Hepatology; 2023 Apr; 77(4):1164-1180. PubMed ID: 35689610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally Occurring TPE-CA Maintains Gut Microbiota and Bile Acids Homeostasis
    Liu L; Liu Z; Li H; Cao Z; Li W; Song Z; Li X; Lu A; Lu C; Liu Y
    Front Pharmacol; 2020; 11():12. PubMed ID: 32116693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis.
    Matye DJ; Wang H; Luo W; Sharp RR; Chen C; Gu L; Jones KL; Ding WX; Friedman JE; Li T
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):1001-1019. PubMed ID: 33965587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 21 ameliorates cholestatic liver injury via a hepatic FGFR4-JNK pathway.
    Zhou C; Pan X; Huang L; Wu T; Zhao T; Qi J; Wu J; Mukondiwa AV; Tang Y; Luo Y; Tu Q; Huang Z; Niu J
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166870. PubMed ID: 37696161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenosides retard atherogenesis via remodelling host-microbiome metabolic homeostasis.
    Wang Y; Wu J; Hong Y; Zhu J; Zhang Y; Zhang J; Ding C; Che Y; Wang G; Jiang A; Hao H; Cao L
    Br J Pharmacol; 2024 Jun; 181(12):1768-1792. PubMed ID: 38355288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitigation of high-fat diet-induced hepatic steatosis by thyme (
    Sheng X; Zhan P; Wang P; He W; Tian H
    Food Funct; 2024 Feb; ():. PubMed ID: 38305590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Western Diet Aggravated Carbon Tetrachloride-Induced Chronic Liver Injury by Disturbing Gut Microbiota and Bile Acid Metabolism.
    Yang L; Li Y; Wang S; Bian X; Jiang X; Wu J; Wang K; Wang Q; Xia J; Jiang S; Zhuge A; Yuan Y; Li S; Li L
    Mol Nutr Food Res; 2021 Apr; 65(7):e2000811. PubMed ID: 33458949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tomato Pectin Ameliorated Hepatic Steatosis in High-Fat-Diet Mice by Modulating Gut Microbiota and Bile Acid Metabolism.
    Wang P; Sun J; Zhao W; Wang D; Ma Y; Zhao Y; Wang Y; Zhao X
    J Agric Food Chem; 2024 Jun; ():. PubMed ID: 38856079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Fat Diet-Induced Decreased Circulating Bile Acids Contribute to Obesity Associated with Gut Microbiota in Mice.
    Cai H; Zhang J; Liu C; Le TN; Lu Y; Feng F; Zhao M
    Foods; 2024 Feb; 13(5):. PubMed ID: 38472812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lonicera Caerulea Juice Alleviates Alcoholic Liver Disease by Regulating Intestinal Flora and the FXR-FGF15 Signaling Pathway.
    Zhang B; Niu L; Huang X
    Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gut microbiota-bile acid axis promotes intestinal homeostasis upon aspirin-mediated damage.
    Li T; Ding N; Guo H; Hua R; Lin Z; Tian H; Yu Y; Fan D; Yuan Z; Gonzalez FJ; Wu Y
    Cell Host Microbe; 2024 Feb; 32(2):191-208.e9. PubMed ID: 38237593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired Bile Acid Metabolism and Gut Dysbiosis in Mice Lacking Lysosomal Acid Lipase.
    Sachdev V; Duta-Mare M; Korbelius M; Vujić N; Leopold C; Freark de Boer J; Rainer S; Fickert P; Kolb D; Kuipers F; Radovic B; Gorkiewicz G; Kratky D
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.